(AVUS) Avantis U.S. Equity - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US0250728856 • Large Blend
AVUS: Equity Securities, Derivative Instruments
The Avantis® U.S. Equity ETF (NYSE ARCA: AVUS) is designed to provide exposure to a broad range of U.S. companies, offering diversification across market sectors, industry groups, and market capitalizations. The fund adheres to a rules-based approach, focusing on companies with strong financial health and profitability metrics. Under normal market conditions, it allocates at least 80% of its assets to U.S. equity securities, including common stocks, REITs, and other equity-related instruments. The fund may also utilize derivative instruments such as futures contracts, currency forwards, and swap agreements to manage risk, enhance returns, or gain market exposure. This ETF is categorized as a Large Blend fund, reflecting its focus on large-cap companies with a mix of growth and value characteristics.
Ticker Symbol: AVUS | Exchange: NYSE ARCA | Type: ETF | Country Origin: USA | ETF Category: Large Blend.
Based on the provided
3-Month Forecast: AVUS is likely to face near-term challenges as it trades below its major moving averages, signaling bearish momentum. However, its large AUM and diversified portfolio may provide downside protection. Investors should monitor technical levels, particularly the SMA 200 at 94.64, as a potential resistance point. Fundamental strength in the U.S. equity market, coupled with the funds rules-based strategy, could support a recovery in the medium term. Expect volatility to remain elevated, with price swings likely bounded by the ATR of 2.70.
Additional Sources for AVUS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AVUS ETF Overview
Market Cap in USD | 7,182m |
Category | Large Blend |
TER | 0.15% |
IPO / Inception | 2019-09-24 |
AVUS ETF Ratings
Growth Rating | 74.7 |
Fundamental | - |
Dividend Rating | 63.6 |
Rel. Strength | -3.7 |
Analysts | - |
Fair Price Momentum | 84.33 USD |
Fair Price DCF | - |
AVUS Dividends
Dividend Yield 12m | 1.38% |
Yield on Cost 5y | 3.00% |
Annual Growth 5y | 10.41% |
Payout Consistency | 100.0% |
AVUS Growth Ratios
Growth Correlation 3m | -89.1% |
Growth Correlation 12m | 47.9% |
Growth Correlation 5y | 83.8% |
CAGR 5y | 16.54% |
CAGR/Max DD 5y | 0.75 |
Sharpe Ratio 12m | 0.61 |
Alpha | -4.12 |
Beta | 0.997 |
Volatility | 37.89% |
Current Volume | 451.5k |
Average Volume 20d | 495.5k |
As of May 01, 2025, the stock is trading at USD 90.63 with a total of 451,491 shares traded.
Over the past week, the price has changed by +2.97%, over one month by -1.89%, over three months by -9.36% and over the past year by +7.73%.
Yes. Based on ValueRay Analyses, Avantis U.S. Equity (NYSE ARCA:AVUS) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 74.68 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AVUS as of May 2025 is 84.33. This means that AVUS is currently overvalued and has a potential downside of -6.95%.
Avantis U.S. Equity has no consensus analysts rating.
According to ValueRays Forecast Model, AVUS Avantis U.S. Equity will be worth about 96.9 in May 2026. The stock is currently trading at 90.63. This means that the stock has a potential upside of +6.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 96.9 | 6.9% |